EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Management of biochemical recurrence after primary curative treatment for prostate cancer: a review
W Artibani, AB Porcaro, V De Marco, MA Cerruto… - Urologia …, 2018 - karger.com
How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR)
following primary curative treatment is a controversial issue. Importantly, this prostate …
following primary curative treatment is a controversial issue. Importantly, this prostate …
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study
Background High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A
clear definition of prognostic subgroups is mandatory. Objective To develop a pretreatment …
clear definition of prognostic subgroups is mandatory. Objective To develop a pretreatment …
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
Background The diagnosis of prostate cancer has long been plagued by the absence of an
imaging tool that reliably detects and localises significant tumours. Recent evidence …
imaging tool that reliably detects and localises significant tumours. Recent evidence …
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer
BACKGROUND: The current role of radical prostatectomy (RP) in patients with high-risk
disease remains controversial. OBJECTIVE: To identify which high-risk prostate cancer …
disease remains controversial. OBJECTIVE: To identify which high-risk prostate cancer …
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks …
BACKGROUND: Survival after surgical treatment using competing-risk analysis has been
previously examined in patients with prostate cancer (PCa). However, the combined effect of …
previously examined in patients with prostate cancer (PCa). However, the combined effect of …
[HTML][HTML] Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center
Background We set to assess the impact of stage migration in prostate cancer (PCa) on the
evolution of the pN1 rate and tumor characteristics in pN1 patients over the last two …
evolution of the pN1 rate and tumor characteristics in pN1 patients over the last two …
Overcoming drug resistance in advanced prostate cancer by drug repurposing
Prostate cancer (PCa) is the second most common cancer in men. Common treatments
include active surveillance, surgery, or radiation. Androgen deprivation therapy and …
include active surveillance, surgery, or radiation. Androgen deprivation therapy and …
Outcomes of very high‐risk prostate cancer after radical prostatectomy: validation study from 3 centers
Background Among men with localized high‐risk prostate cancer (PCa), patients who meet
very high‐risk (VHR) criteria have been shown to experience worse outcomes after radical …
very high‐risk (VHR) criteria have been shown to experience worse outcomes after radical …